Endpoint definition
↥| Name | ILD_SYST_AUTO |
|---|---|
| Long name | ILD related to systemic autoimmune disease |
| Conditions required | ILD_ELSEWHERE |
| Include | ILD_SYST_AUTO_DISEASES |
| First defined in version | DF2 |
ILD related to systemic autoimmune disease
interstitial lung disease: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 411 | 201 | 210 |
| Unadjusted prevalence (%) | 0.19 | 0.16 | 0.22 |
| Mean age at first event (years) | 54.19 | 53.61 | 54.74 |
| Case fatality at 5-years (%) | 4.87 | 4.48 | 5.24 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 4.0 | 4.0 | 4.0 |
| Recurrence at 6 months (%) | 62.85 | 62.84 | 62.85 |
Survival analyses between endpoints
↥Plot
before ILD related to systemic autoimmune disease
after ILD related to systemic autoimmune disease
Loading survival analyses plot…
Table
Loading survival analyses table…